In a nutshell This study examined the safety and effectiveness of stem cell transplantation (SCT) in elderly patients with multiple myeloma (MM) aged 65 or older compared to younger patients. The authors concluded that SCT was equally as safe and effective for patients in both age groups. Some background Multiple myeloma is a complex type of...
Read MoreOn going treatment(s)-Bone marrow transplant-Autologous Posts on Medivizor
Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant
In a nutshell This study evaluated the risk of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) development in patients with lymphoma and myeloma after an autologous stem cell transplant (autoSCT). This study concluded that this risk is quite high after autoSCT in these patients. Some background AML and MDS are known long-term...
Read MoreImpact of multi-drug resistant organisms after stem cell transplantation
In a nutshell This study examined the impact of multi-drug resistant organisms in patients who had undergone stem cell treatment. The study concluded that patients colonized with multi-drug resistant organisms should be watched closely for infections after transplantation. Some background Stem cell transplantation is a treatment used in...
Read MoreExamining lenalidomide as a maintenance therapy for multiple myeloma
In a nutshell This study examined whether lenalidomide (Revlimid) is effective as a maintenance therapy after first-line treatment for multiple myeloma. Researchers concluded that lenalidomide significantly delayed disease progression. Some background High-dose chemotherapy followed by stem cell transplantation is a standard treatment for newly...
Read More
